abstract |
Disclosed are human FGF-10 polypeptides DNA and RNA encoding such FG F-10 polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. Also disclosed are methods for utilizing such polypeptide for stimulating revascularization, for treating wounds and prevent neuronal damage. Antagonists against such polypeptides and their use as a therapeutic to prevent abnormal cellular proliferation, hyper-vascular diseases and epithelial lens cell proliferation are also disclosed. Diagnostic methods for detecting mutations in the FGF-10 coding sequence and alterations in the concentration of FGF-10 protein in a sample derived from a host are also disclosed. |